25I-NB4OMe

Add links
Source: Wikipedia, the free encyclopedia.
25I-NB4OMe
Clinical data
ATC code
  • none
Legal status
Legal status
  • UK:
    Class A drug
Identifiers
  • 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(4-methoxyphenyl)methyl]ethanamine
JSmol)
  • COC1=CC=C(C=C1)CNCCC2=CC(=C(C=C2OC)I)OC
  • InChI=1S/C18H22INO3.ClH/c1-21-15-6-4-13(5-7-15)12-20-9-8-14-10-18(23-3)16(19)11-17(14)22-2;/h4-7,10-11,20H,8-9,12H2,1-3H3;1H
  • Key:NWOROGLTELSWAZ-UHFFFAOYSA-N

25I-NB4OMe (2C-I-NB4OMe, NB4OMe-2C-I) is a derivative of the phenethylamine hallucinogen 2C-I, which acts as a partial agonist for the human 5-HT2A receptor.[1]

Legality

United Kingdom

This substance is a

Class A drug in the United Kingdom as a result of the N-benzylphenethylamine catch-all clause in the Misuse of Drugs Act 1971.[2]

References

  1. PMID 24397362
    .
  2. ^ "The Misuse of Drugs Act 1971 (Ketamine etc.) (Amendment) Order 2014". UK Statutory Instruments 2014 No. 1106. www.legislation.gov.uk.
Retrieved from "https://en.wikipedia.org/w/index.php?title=25I-NB4OMe&oldid=1214808708"